Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases

Genome-wide association studies (GWAS) have led to a rapid increase in available data on common genetic variants and phenotypes and numerous discoveries of new loci associated with susceptibility to common complex diseases. Integrating the evidence from GWAS and candidate gene studies depends on concerted efforts in data production, online publication, database development, and continuously updated data synthesis. Here the authors summarize current experience and challenges on these fronts, which were discussed at a 2008 multidisciplinary workshop sponsored by the Human Genome Epidemiology Network. Comprehensive field synopses that integrate many reported gene-disease associations have been systematically developed for several fields, including Alzheimer's disease, schizophrenia, bladder cancer, coronary heart disease, preterm birth, and DNA repair genes in various cancers. The authors summarize insights from these field synopses and discuss remaining unresolved issues—especially in the light of evidence from GWAS, for which they summarize empirical P-value and effect-size data on 223 discovered associations for binary outcomes (142 with P < 10−7). They also present a vision of collaboration that builds reliable cumulative evidence for genetic associations with common complex diseases and a transparent, distributed, authoritative knowledge base on genetic variation and human health. As a next step in the evolution of Human Genome Epidemiology reviews, the authors invite investigators to submit field synopses for possible publication in the American Journal of Epidemiology.

[1]  J. Ioannidis,et al.  A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. , 2009, Journal of the National Cancer Institute.

[2]  Jon Wakefield,et al.  Bayes factors for genome‐wide association studies: comparison with P‐values , 2009, Genetic epidemiology.

[3]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.

[4]  J. Ioannidis,et al.  Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement , 2009, European Journal of Epidemiology.

[5]  J. Ioannidis Calibration of credibility of agnostic genome‐wide associations , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  J. Ioannidis Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.

[7]  S. Nelson,et al.  Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays , 2008, PLoS genetics.

[8]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[9]  W. Bodmer,et al.  Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.

[10]  M. Daly,et al.  Estimation of the multiple testing burden for genomewide association studies of nearly all common variants , 2008, Genetic epidemiology.

[11]  Francis S Collins,et al.  A HapMap harvest of insights into the genetics of common disease. , 2008, The Journal of clinical investigation.

[12]  A. Singleton,et al.  Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.

[13]  M. McCarthy,et al.  Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes , 2008, Nature Genetics.

[14]  W. Willett,et al.  Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.

[15]  M. Khoury,et al.  A navigator for human genome epidemiology , 2008, Nature Genetics.

[16]  Siobhan M. Dolan,et al.  Assessment of cumulative evidence on genetic associations: interim guidelines. , 2008, International journal of epidemiology.

[17]  C. Hoggart,et al.  Genome‐wide significance for dense SNP and resequencing data , 2008, Genetic epidemiology.

[18]  S. Kingsmore,et al.  Genome-wide association studies: progress and potential for drug discovery and development , 2008, Nature Reviews Drug Discovery.

[19]  John P A Ioannidis,et al.  Required sample size and nonreplicability thresholds for heterogeneous genetic associations , 2008, Proceedings of the National Academy of Sciences.

[20]  Muin J. Khoury,et al.  Letting the genome out of the bottle--will we get our wish? , 2008, The New England journal of medicine.

[21]  Ncbi National Center for Biotechnology Information , 2008 .

[22]  Positively disruptive , 2008, Nature Genetics.

[23]  Nikolaos A Patsopoulos,et al.  Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.

[24]  Evangelos Evangelou,et al.  Heterogeneity in Meta-Analyses of Genome-Wide Association Investigations , 2007, PloS one.

[25]  Jon Wakefield,et al.  A Bayesian measure of the probability of false discovery in genetic epidemiology studies. , 2007, American journal of human genetics.

[26]  Eric J Topol,et al.  The genomics gold rush. , 2007, JAMA.

[27]  P. Donnelly,et al.  Replicating genotype–phenotype associations , 2007, Nature.

[28]  John P.A. Ioannidis,et al.  Non-Replication and Inconsistency in the Genome-Wide Association Setting , 2007, Human Heredity.

[29]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[30]  J. Ioannidis,et al.  An exploratory test for an excess of significant findings , 2007, Clinical trials.

[31]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[32]  J. Pritchard,et al.  Overcoming the winner's curse: estimating penetrance parameters from case-control data. , 2007, American journal of human genetics.

[33]  R. Cotton Recommendations of the 2006 Human Variome Project meeting , 2007, Nature Genetics.

[34]  N. Rothman,et al.  Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned. , 2007, International journal of epidemiology.

[35]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[36]  Roger M Harbord,et al.  A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.

[37]  Roberta A Pagon,et al.  GeneTests: an online genetic information resource for health care providers. , 2006, Journal of the Medical Library Association : JMLA.

[38]  M. Khoury,et al.  Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. , 2006, American journal of epidemiology.

[39]  A. Zlotta NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses , 2006 .

[40]  Emily Waltz,et al.  US ponders unlocking the gates to prisoner research , 2006, Nature medicine.

[41]  K. Vogan Embracing risk , 2006, Nature Genetics.

[42]  Paolo Vineis,et al.  A road map for efficient and reliable human genome epidemiology , 2006, Nature Genetics.

[43]  Paolo Vineis,et al.  A network of investigator networks in human genome epidemiology. , 2005, American journal of epidemiology.

[44]  J. Ioannidis Why Most Published Research Findings Are False , 2005, PLoS medicine.

[45]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[46]  B. Charlesworth,et al.  A polygenic basis for late-onset disease. , 2003, Trends in genetics : TIG.

[47]  C. Mangano Risky business. , 2003, The Journal of thoracic and cardiovascular surgery.

[48]  Joshua M. Stuart,et al.  Integrating genotype and phenotype information: an overview of the PharmGKB project , 2001, The Pharmacogenomics Journal.

[49]  R. Elston,et al.  Ascertainment adjustment: where does it take us? , 2000, American journal of human genetics.

[50]  M. Khoury,et al.  The Human Genome Epidemiology Network. , 1998, American journal of epidemiology.

[51]  W. Raub From the National Institutes of Health. , 1990, JAMA.